Deutsche Bank Ag\ Sarepta Therapeutics, Inc. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
A detailed history of Deutsche Bank Ag\ transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,463,176 shares of SRPT stock, worth $165 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,463,176
Previous 1,573,577
7.02%
Holding current value
$165 Million
Previous $249 Million
26.5%
% of portfolio
0.08%
Previous 0.11%
Shares
32 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
85MCall Options Held
1.74MPut Options Held
1.37M-
Black Rock Inc. New York, NY10.3MShares$1.16 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.01 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$706 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$491 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$481 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.87B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...